GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hindustan Bio Sciences Ltd (BOM:532041) » Definitions » EV-to-FCF

Hindustan Bio Sciences (BOM:532041) EV-to-FCF : (As of May. 27, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Hindustan Bio Sciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Hindustan Bio Sciences's Enterprise Value is ₹113.48 Mil. Hindustan Bio Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00 Mil. Therefore, Hindustan Bio Sciences's EV-to-FCF for today is .

The historical rank and industry rank for Hindustan Bio Sciences's EV-to-FCF or its related term are showing as below:

BOM:532041' s EV-to-FCF Range Over the Past 10 Years
Min: -346.76   Med: 0   Max: 0
Current: -227.88

BOM:532041's EV-to-FCF is ranked worse than
100% of 528 companies
in the Drug Manufacturers industry
Industry Median: 24.695 vs BOM:532041: -227.88

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Hindustan Bio Sciences's stock price is ₹8.55. Hindustan Bio Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.140. Therefore, Hindustan Bio Sciences's PE Ratio for today is 61.07.


Hindustan Bio Sciences EV-to-FCF Historical Data

The historical data trend for Hindustan Bio Sciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hindustan Bio Sciences EV-to-FCF Chart

Hindustan Bio Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.11 4.72 6.53 -18.72 -158.62

Hindustan Bio Sciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -158.62 - -

Competitive Comparison of Hindustan Bio Sciences's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hindustan Bio Sciences's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Hindustan Bio Sciences's EV-to-FCF falls into.



Hindustan Bio Sciences EV-to-FCF Calculation

Hindustan Bio Sciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=113.483/0
=

Hindustan Bio Sciences's current Enterprise Value is ₹113.48 Mil.
Hindustan Bio Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hindustan Bio Sciences  (BOM:532041) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Hindustan Bio Sciences's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=8.55/0.140
=61.07

Hindustan Bio Sciences's share price for today is ₹8.55.
Hindustan Bio Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.140.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Hindustan Bio Sciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Hindustan Bio Sciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Hindustan Bio Sciences (BOM:532041) Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.

Hindustan Bio Sciences (BOM:532041) Headlines

No Headlines